Safety and efficacy of anakinra as first-line or second-line therapy for systemic onset juvenile idiopathic arthritis - data from the German BIKER registry.

Conclusion: The current analysis adds to the established safety profile of anakinra and demonstrates that anakinra is effective as first-line or second-line treatment. PMID: 33148061 [PubMed - as supplied by publisher]
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research